(MedPage Today) -- Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus (RSV) had a lower rate of related hospitalizations and severe outcomes than...

(MedPage Today) -- Use of benzodiazepines during pregnancy, particularly in the second trimester, was linked to some adverse pregnancy outcomes, a Taiwanese cohort study found. Among 454,477 pregnancies, benzodiazepine use...

(MedPage Today) -- The FDA gave the greenlight to use total hip bone mineral density (BMD) as a validated surrogate endpoint for clinical osteoporosis drug trials, the FDA announced on...

(MedPage Today) -- Nearly one in two transgender and gender diverse (TGD) youth reported suicidal ideation or self-injury, and one in four attempted suicide, a global meta-analysis showed. In a...

(MedPage Today) -- When a woman in her mid-40s underwent a single, genetically normal embryo transfer, clinicians expected -- and counseled for -- a singleton pregnancy. What followed instead was...

(MedPage Today) -- Hydroxychloroquine (HCQ) doses of at least 400 mg/day provided better symptom relief for Taiwanese people with systemic lupus erythematosus (SLE) compared with lower doses, with the added...

Research across Europe suggests creative environments can support well-being, ease burnout, and reshape how care settings work for patients, staff, and visitors. Medscape News Europe Source link : https://www.medscape.com/viewarticle/art-missing-tool-modern-healthcare-2025a1001011?src=rss Author...

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, investigators presented results from HER2CLIMB-05, a registrational trial evaluating the addition of tucatinib (Tukysa) to trastuzumab (Herceptin) and pertuzumab (Perjeta)...

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen-receptor degrader (SERD) giredestrant significantly reduced recurrence risk compared with...

(MedPage Today) -- At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for patients with previously untreated follicular lymphoma with...

(MedPage Today) -- The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced. Aficamten is an allosteric and reversible inhibitor of cardiac myosin motor...

Our successful request for Peter Kyle’s ChatGPT logs stunned observersTada Images/Victoria Jones/Shutterstock When I fired off an email at the start of 2025, I hadn’t intended to set a legal...

(MedPage Today) -- President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb,...

The afternoon of 7 August 1996 isn’t a time that sticks in many people’s minds. But if things had worked out differently, it might have been etched into our collective...

(MedPage Today) -- At the recent American Society of Hematology annual meeting, real-world analyses examined how polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP) is being adopted outside...

(MedPage Today) -- Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a dose-related fashion, a...

(MedPage Today) -- It's the time of year again to deck the halls and get on your jingle jolly way, and with my holiday party date fast approaching I wondered...

(MedPage Today) -- Note that some links may require registration or subscription. Some cheddar cheese products branded as Charlevoix Cheese Company Farm have been recalled due to potential Listeria contamination....

Tec-Dara shows treatment effects in RRMM after just one prior line of therapy. Medscape Medical News Source link : https://www.medscape.com/viewarticle/novel-treatment-combo-ups-survival-multiple-myeloma-2025a1000zz9?src=rss Author : Publish date : 2025-12-22 13:34:00 Copyright for syndicated...

Acute care after hallucinogen use is linked to a significantly increased risk for incident mania or bipolar disorder within 3 years, a new study shows. Medscape Medical News Source link...